Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

FDA Approves First Quadrivalent Flu Vaccine

FDA Approves First Quadrivalent Flu Vaccine
RELATED NEWS
Trade AZN now with 
3/1/2012 5:10 AM ET

FluMist Quadrivalent, a vaccine developed by AstraZeneca plc's (AZN: Quote) MedImmune unit, has been approved by the FDA for the prevention of seasonal influenza in people aged 2 years through 49 years.

FluMist Quadrivalent is the first influenza vaccine to contain four strains of the influenza virus - two influenza A strains and two influenza B strains. All other currently available licensed seasonal influenza vaccines, are trivalent, containing only three influenza virus strains namely, two strains of influenza A and one of influenza B.

Some of the approved trivalent flu vaccines are CSL Biotherapies' Afluria; Novartis' Agriflu; GlaxoSmithKline's Fluarix; ID Biomedical Corp.'s FluLaval; MedImmune's FluMist, and Sanofi Pasteur Inc.'s Fluzone and Fluzone High-Dose.

According to federal health officials, FluMist Quadrivalent increases the likelihood of adequate protection against circulating influenza B strains.

The newly approved FluMist Quadrivalent is administered as a spray into the nose, similar to the trivalent FluMist vaccine.

Influenza, commonly referred to as flu, is a contagious viral infection, associated with aches, pains, tiredness, sore throat and a runny nose. The symptoms may last from three to five days and can make a person quite ill for a few weeks.

Register
To receive FREE breaking news email alerts for AstraZeneca PLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Chipmaker Advanced Micro Devices Inc. said Thursday after the markets closed that its first quarter loss narrowed from last year, helped by strong revenue growth in its graphics and visual solutions business. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarterly revenue. After trending higher over the past few sessions, stocks showed a lack of direction throughout the trading day on Thursday. The major averages spent the session bouncing back and forth across the unchanged line before ending the day mixed. While the major averages closed on opposite sides of the unchanged line, they all showed only modest moves. U.S. Secretary Of State John Kerry said Thursday that he and his counterparts from Russia, Ukraine and the European Union have reached an agreement on a preliminary plan for ending the ongoing crisis in Ukraine. Kerry was speaking at the end of the Ukraine contact group's first meeting, comprising the foreign ministers of Russia, Ukraine, the EU and the U.S., in the Swiss city of Geneva.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.